Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04280289 · ClinicalTrials.gov registry record · Early Phase 1
CBD Cannabis Extract: Pharmacokinetic Studies
A Early Phase 1 study, sponsored by University of Mississippi, Oxford.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
NCT04280289: Completed Early Phase 1 study, sponsored by University of Mississippi, Oxford.
NCT04280289 is a Early Phase 1 study that has completed, run by University of Mississippi, Oxford. The registered enrollment target is 10 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04280289, a Early Phase 1 study, has completed, sponsored by University of Mississippi, Oxford.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The initial goal is to ascertain the pharmacokinetic (PK) profile of CBD (cannabidiol) after a single dose of CBDE (cannabidiol extract), although the plan is to extend these studies to multiple dose administrations in the future, since it is likely that (cannabidiol) and/or its metabolites will show some accumulation. These studies will provide detailed information that will inform the continuation and expansion of CBDE in other research projects.
Primary Outcome
This study would provide information on differential pharmacokinetics and metabolism of Cannabis extract in normal human volunteers
Interventions
- DRUG cannabidiol extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2021-12-01 |
| Phase | Early Phase 1 |
What the finished NCT04280289 record still lists
NCT04280289 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 1 intervention - of which cannabidiol extract is the first listed.
NCT04280289 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04280289 about?
NCT04280289 is a clinical study titled "CBD Cannabis Extract: Pharmacokinetic Studies". The initial goal is to ascertain the pharmacokinetic (PK) profile of CBD (cannabidiol) after a single dose of CBDE (cannabidiol extract), although the plan is to extend these studies to multiple dose administrations in the future, since it is likely that (cannabidiol) and/or its metabolites will sho...
What is the current status of trial NCT04280289?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2021-02-01. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT04280289?
The interventions under investigation include: cannabidiol extract (DRUG).
Who is sponsoring clinical trial NCT04280289?
This trial is sponsored by University of Mississippi, Oxford, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04280289's enrollment target sits among peer trials
10 1629th of 2000 higher than 256 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI